Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotech Business
NanoTox® Continues to Attract Dynamic Leaders with Addition of La Jolla Capital Partners CEO, C. Richard Piazza, to Board of Directors
April 18th, 2009
nanoTox, the first company to provide complete risk analysis and profiling exclusively for nanoparticles, announced that C. Richard Piazza has joined the board of directors of its parent company Nano Risk Assessment, Inc. Mr. Piazza is founder and CEO of private equity firm La Jolla Capital Partners, LLC and an established leader in the biotechnology and pharmaceutical industries. "We look forward to gaining from Mr. Piazza's vast knowledge," said Harry Bushong, president of nanoTox. "With his decades of experience leading prominent biotech and pharmaceutical companies to profitability, Mr. Piazza's insights and direction will be instrumental in assuring the success of...
Source: Law & Health Weekly (2009-04-18)
|
